4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001077
Chief Accounting Officer sold 968 shares at $16.65 ($16,117)
- Chief Accounting Officer acquired 968 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolte Alexander Chief Accounting Officer | 2022-01-31 | Other acquisition | +968 | $12.39 | $11,994 | 968 | D: show line 1 in the form |
| Nolte Alexander Chief Accounting Officer | 2022-02-01 | Sale | −968 | $16.65 | $16,117 | 0 | D: show line 2 in the form |
| Open-market sales · 968 sh · avg $16.65 · $16,117 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolte Alexander Chief Accounting Officer | 2022-02-02 | Grant or award · Stock Options (Right to buy) | +30,000 | $15.79 | $473,700 | 30,000 | D: show line 3 in the form |
Loading xslF345X03/primarydocument.xml…